Revised criteria for the diagnosis and staging of Alzheimer’s disease

Clifford R. Jack; Scott J. Andrews; Thomas G. Beach; Teresa Buracchio; Billy Dunn; Ana Graf; Oskar Hansson; Carole Ho; William Jagust; Eric McDade; Jose Luis Molinuevo; Ozioma C. Okonkwo; Luca Pani; Michael S. Rafii; Philip Scheltens; Eric Siemers; Heather M. Snyder; Reisa Sperling; Charlotte E. Teunissen; Maria C. Carrillo

doi:10.1038/s41591-024-02988-7

Revised criteria for the diagnosis and staging of Alzheimer’s disease

Clifford R. Jack
, Scott J. Andrews
, Thomas G. Beach
, Teresa Buracchio
, Billy Dunn
, Ana Graf
, Oskar Hansson
, Carole Ho
, William Jagust
, Eric McDade
, Jose Luis Molinuevo
, Ozioma C. Okonkwo
, Luca Pani
, Michael S. Rafii
, Philip Scheltens
, Eric Siemers
, Heather M. Snyder
, Reisa Sperling
, Charlotte E. Teunissen
, Maria C. Carrillo

Hope Center for Neurological Disorders

Research output: Contribution to journal › Comment/debate

113 Scopus citations

Abstract

Alzheimer’s disease can be treated by targeting amyloid-β plaques and diagnosed in vivo by biomarkers, prompting the revision of criteria for the diagnosis and staging of this disease.

Original language	English
Pages (from-to)	2121-2124
Number of pages	4
Journal	Nature medicine
Volume	30
Issue number	8
DOIs	https://doi.org/10.1038/s41591-024-02988-7
State	Published - Aug 2024

Access to Document

10.1038/s41591-024-02988-7

Cite this

Jack, C. R., Andrews, S. J., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., Molinuevo, J. L., Okonkwo, O. C., Pani, L., Rafii, M. S., Scheltens, P., Siemers, E., Snyder, H. M., Sperling, R., Teunissen, C. E., & Carrillo, M. C. (2024). Revised criteria for the diagnosis and staging of Alzheimer’s disease. Nature medicine, 30(8), 2121-2124. https://doi.org/10.1038/s41591-024-02988-7

@article{1aa751b769114eaeb9a29acea97066cf,

title = "Revised criteria for the diagnosis and staging of Alzheimer{\textquoteright}s disease",

abstract = "Alzheimer{\textquoteright}s disease can be treated by targeting amyloid-β plaques and diagnosed in vivo by biomarkers, prompting the revision of criteria for the diagnosis and staging of this disease.",

author = "Jack, \{Clifford R.\} and Andrews, \{Scott J.\} and Beach, \{Thomas G.\} and Teresa Buracchio and Billy Dunn and Ana Graf and Oskar Hansson and Carole Ho and William Jagust and Eric McDade and Molinuevo, \{Jose Luis\} and Okonkwo, \{Ozioma C.\} and Luca Pani and Rafii, \{Michael S.\} and Philip Scheltens and Eric Siemers and Snyder, \{Heather M.\} and Reisa Sperling and Teunissen, \{Charlotte E.\} and Carrillo, \{Maria C.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature America, Inc. 2024.",

year = "2024",

month = aug,

doi = "10.1038/s41591-024-02988-7",

language = "English",

volume = "30",

pages = "2121--2124",

journal = "Nature medicine",

issn = "1078-8956",

number = "8",

}

Jack, CR, Andrews, SJ, Beach, TG, Buracchio, T, Dunn, B, Graf, A, Hansson, O, Ho, C, Jagust, W, McDade, E, Molinuevo, JL, Okonkwo, OC, Pani, L, Rafii, MS, Scheltens, P, Siemers, E, Snyder, HM, Sperling, R, Teunissen, CE & Carrillo, MC 2024, 'Revised criteria for the diagnosis and staging of Alzheimer’s disease', Nature medicine, vol. 30, no. 8, pp. 2121-2124. https://doi.org/10.1038/s41591-024-02988-7

TY - JOUR

T1 - Revised criteria for the diagnosis and staging of Alzheimer’s disease

AU - Jack, Clifford R.

AU - Andrews, Scott J.

AU - Beach, Thomas G.

AU - Buracchio, Teresa

AU - Dunn, Billy

AU - Graf, Ana

AU - Hansson, Oskar

AU - Ho, Carole

AU - Jagust, William

AU - McDade, Eric

AU - Molinuevo, Jose Luis

AU - Okonkwo, Ozioma C.

AU - Pani, Luca

AU - Rafii, Michael S.

AU - Scheltens, Philip

AU - Siemers, Eric

AU - Snyder, Heather M.

AU - Sperling, Reisa

AU - Teunissen, Charlotte E.

AU - Carrillo, Maria C.

PY - 2024/8

Y1 - 2024/8

N2 - Alzheimer’s disease can be treated by targeting amyloid-β plaques and diagnosed in vivo by biomarkers, prompting the revision of criteria for the diagnosis and staging of this disease.

AB - Alzheimer’s disease can be treated by targeting amyloid-β plaques and diagnosed in vivo by biomarkers, prompting the revision of criteria for the diagnosis and staging of this disease.

UR - https://www.scopus.com/pages/publications/85197426179

U2 - 10.1038/s41591-024-02988-7

DO - 10.1038/s41591-024-02988-7

M3 - Comment/debate

C2 - 38942991

AN - SCOPUS:85197426179

SN - 1078-8956

VL - 30

SP - 2121

EP - 2124

JO - Nature medicine

JF - Nature medicine

IS - 8

ER -

Revised criteria for the diagnosis and staging of Alzheimer’s disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this